Bioton (LTS:0DTR) FFO


LTS:0DTR Bioton SA LTS:0DTR
68 GF Score
Price zł3.43
GF Value zł4.08
! 3 Warning Signs
View Full Analysis

What is Bioton FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0DTR
68GF Score
Bioton SA LTS:0DTR
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bioton (LTS:0DTR) Overvalued in 2026?

Based on GuruFocus' analysis, Bioton stock appears to be undervalued. The current stock price of zł3.43 is trading 16% below its estimated GF Value™ of zł4.08.

Key valuation signals for LTS:0DTR:

  • FFO:
  • GF Value™: zł4.08 vs. price of zł3.43 (16% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the LTS:0DTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bioton Business Description

Other Exchanges BIO:Poland7U5:Germany
Address Ul. Starościńska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.
68GF Score

Get the complete analysis for LTS:0DTR

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.43
Price
zł4.08
GF Value